Your browser is no longer supported. Please, upgrade your browser.
Settings
PEN Penumbra, Inc. daily Stock Chart
PEN [NYSE]
Penumbra, Inc.
Index- P/E- EPS (ttm)-0.71 Insider Own1.80% Shs Outstand36.21M Perf Week-7.37%
Market Cap7.49B Forward P/E218.64 EPS next Y0.96 Insider Trans-12.53% Shs Float33.92M Perf Month-15.71%
Income-25.30M PEG- EPS next Q0.08 Inst Own90.20% Short Float13.54% Perf Quarter1.69%
Sales538.80M P/S13.90 EPS this Y622.30% Inst Trans5.77% Short Ratio9.20 Perf Half Y17.80%
Book/sh17.19 P/B12.21 EPS next Y664.70% ROA-1.30% Target Price270.17 Perf Year23.78%
Cash/sh7.53 P/C27.87 EPS next 5Y49.70% ROE-1.70% 52W Range121.80 - 277.00 Perf YTD27.77%
Dividend- P/FCF- EPS past 5Y118.50% ROI8.60% 52W High-24.23% Beta0.49
Dividend %- Quick Ratio3.70 Sales past 5Y34.30% Gross Margin63.50% 52W Low72.32% ATR14.00
Employees2700 Current Ratio5.50 Sales Q/Q8.30% Oper. Margin-4.90% RSI (14)36.23 Volatility6.39% 5.89%
OptionableYes Debt/Eq0.05 EPS Q/Q-262.90% Profit Margin-1.80% Rel Volume1.22 Prev Close206.25
ShortableYes LT Debt/Eq0.04 EarningsOct 28 AMC Payout- Avg Volume499.18K Price209.89
Recom1.60 SMA20-14.12% SMA50-7.79% SMA2006.64% Volume611,108 Change1.76%
Oct-07-20Resumed Canaccord Genuity Buy $253
Sep-29-20Initiated BTIG Research Buy $233
Sep-08-20Downgrade BofA Securities Buy → Neutral
Mar-05-20Initiated Citigroup Buy $200
Jun-13-19Reiterated BofA/Merrill Buy $150 → $180
May-30-19Upgrade JP Morgan Neutral → Overweight
May-21-19Initiated William Blair Outperform
Oct-29-18Resumed BofA/Merrill Buy $36
Oct-08-18Initiated RBC Capital Mkts Outperform $174
Feb-21-18Initiated William Blair Outperform
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Nov-30-15Reiterated Canaccord Genuity Buy $50 → $58
Oct-13-15Initiated Wells Fargo Outperform
Dec-04-20 07:00PM  
03:50PM  
Nov-20-20 08:00AM  
Nov-13-20 04:30PM  
Nov-10-20 09:39AM  
06:00AM  
Nov-06-20 04:05PM  
Oct-29-20 12:45PM  
07:30AM  
07:20AM  
Oct-28-20 08:01PM  
06:45PM  
04:05PM  
02:30PM  
Oct-27-20 11:48AM  
Oct-21-20 12:32PM  
Oct-12-20 04:20PM  
Sep-29-20 04:05PM  
Sep-03-20 04:05PM  
Aug-26-20 04:05PM  
Aug-14-20 12:15AM  
Aug-12-20 11:07AM  
11:00AM  
Aug-03-20 10:30PM  
06:25PM  
04:15PM  
04:05PM  
12:13PM  
Jul-27-20 12:31PM  
Jul-24-20 10:07AM  
05:36AM  
Jul-20-20 04:05PM  
Jul-14-20 09:00AM  
Jun-19-20 11:56AM  
Jun-12-20 02:27AM  
May-29-20 04:05PM  
May-27-20 09:38PM  
04:05PM  
May-15-20 04:05PM  
May-12-20 04:05PM  
May-08-20 03:31AM  
May-06-20 09:07AM  
May-01-20 04:55PM  
Apr-30-20 12:34PM  
Apr-29-20 05:50PM  
04:05PM  
Apr-23-20 04:05PM  
Apr-09-20 05:23AM  
Apr-06-20 04:05PM  
Mar-26-20 01:06PM  
Mar-25-20 02:45PM  
Mar-19-20 09:39AM  
Mar-16-20 12:45PM  
Mar-09-20 09:00AM  
Mar-06-20 09:56AM  
Feb-28-20 12:45PM  
Feb-26-20 09:03AM  
Feb-25-20 06:55PM  
Feb-17-20 05:44PM  
Feb-14-20 05:00AM  
Feb-12-20 10:06AM  
Feb-11-20 04:05PM  
Jan-31-20 09:55AM  
Jan-28-20 09:52AM  
Jan-10-20 06:00PM  
Jan-09-20 08:30AM  
Jan-07-20 02:27PM  
Dec-31-19 04:05PM  
Dec-25-19 04:57AM  
Dec-07-19 06:08PM  
Nov-25-19 04:05PM  
Nov-19-19 04:05PM  
09:18AM  
Nov-14-19 09:11AM  
Nov-11-19 07:34AM  
Nov-07-19 07:35PM  
04:05PM  
Nov-06-19 04:53PM  
09:42AM  
Oct-31-19 10:33AM  
Oct-23-19 08:56AM  
Oct-17-19 04:05PM  
Oct-11-19 11:03AM  
10:13AM  
09:59AM  
Oct-10-19 09:00AM  
Sep-13-19 09:15PM  
Sep-06-19 06:00PM  
Sep-04-19 10:50PM  
Aug-29-19 04:05PM  
Aug-27-19 04:05PM  
08:17AM  
Aug-21-19 10:15PM  
Aug-15-19 01:16AM  
Aug-06-19 10:51PM  
06:45PM  
04:05PM  
Aug-02-19 11:15PM  
Aug-01-19 09:15AM  
Jul-31-19 01:07PM  
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; rehabilitation tools that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pray James RobertPresident, InternationalDec 01Sale215.935,0001,079,655433,431Dec 03 08:41 PM
Rothman LynnEVP and Chief Business OfficerNov 24Option Exercise3.9810,15040,39722,482Nov 25 08:33 PM
Pray James RobertPresident, InternationalNov 17Sale258.615,0001,293,039438,431Nov 19 08:37 PM
Grewal HarpreetDirectorNov 16Sale262.77567148,99112,828Nov 18 08:38 PM
O'Rourke BridgetDirectorNov 13Sale271.466517,6453,128Nov 17 08:34 PM
Elsesser AdamCEO and PresidentNov 11Sale265.168,0002,121,260965,582Nov 13 09:06 PM
Bose AraniChief InnovatorNov 10Sale255.437,9982,042,957550,662Nov 13 09:03 PM
Bose AraniChief InnovatorNov 09Sale255.9910025,599558,660Nov 09 09:03 PM
Bose AraniChief InnovatorNov 05Sale255.191,902485,371558,760Nov 09 09:03 PM
O'Rourke BridgetDirectorOct 13Sale207.586513,4933,193Oct 15 08:23 PM
Elsesser AdamCEO and PresidentOct 12Sale212.648,0001,701,146973,582Oct 14 08:51 PM
Kassing Don W.DirectorOct 09Sale209.76712149,347993Oct 14 08:46 PM
Wilder ThomasDirectorOct 01Sale196.0611522,547263Oct 05 08:48 PM
O'Rourke BridgetDirectorSep 14Sale200.976513,0633,258Sep 16 07:49 PM
Elsesser AdamCEO and PresidentSep 11Sale200.738,0001,605,862981,582Sep 15 08:52 PM
Pray James RobertPresident, InternationalSep 01Sale212.745,0001,063,678443,431Sep 03 08:13 PM
Pray James RobertPresident, InternationalAug 18Sale235.115,0001,175,537448,431Aug 20 07:39 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryAug 17Sale236.072,000472,14550,761Aug 19 08:21 PM
O'Rourke BridgetDirectorAug 13Sale237.166515,4153,323Aug 17 08:54 PM
Elsesser AdamCEO and PresidentAug 11Sale232.158,0001,857,160989,582Aug 13 09:18 PM
Rothman LynnEVP and Chief Business OfficerJul 20Option Exercise3.984,87519,40317,207Jul 21 09:42 PM
Rothman LynnEVP and Chief Business OfficerJul 20Sale200.074,875975,34112,332Jul 21 09:42 PM
Rothman LynnEVP and Chief Business OfficerJul 17Option Exercise3.984,80019,10417,132Jul 21 09:42 PM
Rothman LynnEVP and Chief Business OfficerJul 17Sale195.124,800936,57612,332Jul 21 09:42 PM
O'Rourke BridgetDirectorJul 17Sale189.23468,7053,388Jul 21 09:39 PM
Rothman LynnEVP and Chief Business OfficerJul 13Option Exercise3.9820079612,532Jul 15 08:53 PM
O'Rourke BridgetDirectorJul 13Sale192.4718936,3773,434Jul 15 08:45 PM
Wilder ThomasDirectorJul 13Sale192.4723044,268526Jul 15 08:48 PM
Elsesser AdamCEO and PresidentJul 13Sale191.908,0001,535,167997,582Jul 15 08:50 PM
Rothman LynnEVP and Chief Business OfficerJul 13Sale195.0020039,00012,332Jul 15 08:53 PM
Elsesser AdamCEO and PresidentJun 11Sale166.888,0001,335,0621,005,582Jun 15 08:35 PM
Elsesser AdamCEO and PresidentMay 11Sale187.678,0001,501,3561,013,582May 13 08:20 PM
Bose AraniChief InnovatorMay 07Sale185.0710,0001,850,700560,662May 11 08:12 PM
Bose AraniChief InnovatorApr 23Sale185.539,1001,688,286570,662Apr 27 08:23 PM
Bose AraniChief InnovatorApr 20Sale185.11900166,599579,762Apr 22 07:47 PM
Kosaraju SridharPresidentApr 15Sale169.282,500423,204155,351Apr 17 09:08 PM
Elsesser AdamChief Executive OfficerApr 13Sale157.818,0001,262,4931,021,582Apr 15 08:48 PM
O'Rourke BridgetDirectorApr 06Sale162.56447,1533,623Apr 08 08:06 PM
Kosaraju SridharPresidentMar 16Sale154.362,500385,901157,851Mar 18 07:55 PM
Elsesser AdamChief Executive OfficerMar 09Sale172.018,0001,376,0961,029,582Mar 11 08:10 PM
Kassing Don W.DirectorFeb 24Sale186.3030456,6351,705Feb 26 08:06 PM
Kosaraju SridharPresidentFeb 18Sale190.702,500476,761160,351Feb 20 08:03 PM
Rothman LynnEVP and Chief Business OfficerFeb 11Option Exercise3.985,00019,90017,332Feb 13 08:41 PM
Rothman LynnEVP and Chief Business OfficerFeb 11Sale185.255,000926,25012,332Feb 13 08:41 PM
Bose AraniChief InnovatorFeb 11Sale185.3010,0001,853,000580,662Feb 13 08:38 PM
Rothman LynnEVP and Chief Business OfficerJan 30Option Exercise3.9810,00039,80022,332Feb 03 08:22 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryJan 30Sale176.253,500616,89254,056Feb 03 08:28 PM
Rothman LynnEVP and Chief Business OfficerJan 30Sale176.0110,0001,760,10812,332Feb 03 08:22 PM
Kosaraju SridharPresidentJan 30Sale176.152,500440,373163,851Feb 03 08:18 PM
O'Rourke BridgetDirectorJan 27Sale172.5016328,1172,911Jan 29 08:10 PM
Sarna SurbhiDirectorJan 27Sale168.7927346,0801,035Jan 29 08:04 PM
Wilder ThomasDirectorJan 02Sale164.1611819,371238Jan 03 08:36 PM
Pray James RobertPresident, InternationalJan 02Sale163.175,335870,517453,431Jan 03 08:32 PM
Grewal HarpreetDirectorJan 02Sale164.1623738,90612,639Jan 03 08:28 PM
Rothman LynnEVP and Chief Business OfficerDec 27Option Exercise3.983201,27412,332Dec 30 08:31 PM
Elsesser AdamChairman and CEODec 11Sale156.648,0001,253,1011,050,982Dec 13 07:57 PM